Skip to main content

Table 3 One- and five-year mortality rate ratios (MRRs) by level of comorbidity. The corresponding 95% confidence interval is given in parentheses.

From: The impact of comorbidity and stage on ovarian cancer mortality: A nationwide Danish cohort study

 

Charlson Comorbidity score

 

0

1–2

3+

N (%)

3,727 (72%)

1,116 (21%)

370 (7%)

1-year

   

   Survival in %

73 (71–74)

58 (55–60)

44 (39–49)

   MRR

1 (ref.)

1.8 (1.6–2.0)

2.7 (2.3–3.1)

   Adj. MRR*

1 (ref.)

1.4 (1.2–1.5)

2.0 (1.7–2.3)

   Adj. MRR**

1 (ref.)

1.3 (1.2–1.5)

1.8 (1.6–2.1)

5-year

   

   Survival in %

37 (36–39)

24 (21–27)

12 (8–16)

   MRR

1 (ref.)

1.5 (1.4–1.6)

2.3 (2.1–2.6)

   Adj. MRR*

1 (ref.)

1.3 (1.2–1.4)

1.8 (1.6–2.1)

   Adj. MRR**

1 (ref.)

1.2 (1.1–1.4)

1.7 (1.5–1.9)

  1. *Adjusted for age and calendar time.
  2. **Adjusted for age, calendar time and stage.